According to a study from York university the amount of prescription drugs in Italy have been reduced significantly after the introduction of CBD flower buds.
In June a four person medical board panel in Ohio will recommend some additions to the list of legal medical cannabis. Anxiety and autism spectrum disorder are the newcomers.
According to a new American study cannabis can give MS patients considerable ease regarding symptoms and pain conditions.
In the wake of cannabis legalization pharmacists in the province of Ontario now have to undergo a mandatory cannabis course in order to keep practising.
Farmako is a German pharmaceutical company from Frankfurt. They just registered a patent that will make a modified tequila bacterium produce THC and CBD from sugar.
Last year the Swedish medicinal company Enorama Pharma got permission from the Swedish Medical Products Agency to import and handle cannabis. They are now developing their medical cannabis chewing gum for the rapidly expanding global market.
The Multiple Sclerosis Society of Canada is investing $1.5 million in a new, never before researched study. They are teaming up with the Canadian Institutes of Health Research to perform this research. The goal is to see if MS could be treated with cannabis.
Could cannabis help stopping drug addictions? It almost seems that way. According to a recent study it looks promising.
Gabriel Micallef is a pharmaceutical expert. Here he gives his view of what the future medical cannabis market in Europe could look like.
According to a General Social Survey from 2018 cannabis is gaining a record high support. 61% are backing legalization and seniors are getting more supportive by the day!